{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:53:27Z","timestamp":1782287607760,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08578"],"award-info":[{"award-number":["22K08578"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012313","name":"Interdisciplinary Cluster for Cutting Edge Research, Shinshu University","doi-asserted-by":"publisher","award":["2019-2022"],"award-info":[{"award-number":["2019-2022"]}],"id":[{"id":"10.13039\/501100012313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12033-023-00741-y","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T15:02:11Z","timestamp":1681570931000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a Single-Chain Fragment Variable that Binds to the SARS-CoV-2 Spike Protein Produced by Genetically Modified Lactic Acid Bacteria"],"prefix":"10.1007","volume":"66","author":[{"given":"Suzuka","family":"Oshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Namai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8132-1911","authenticated-orcid":false,"given":"Takeshi","family":"Shimosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"key":"741_CR1","unstructured":"WHO (2022) COVID-19 weekly epidemiological update, edition 119, 23 November 2022"},{"key":"741_CR2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-020-0732-3","volume":"15","author":"HF Florindo","year":"2020","unstructured":"Florindo, H. F., Kleiner, R., Vaskovich-Koubi, D., Acurcio, R. C., Carreira, B., Yeini, E., Tiram, G., Liubomirski, Y., & Satchi-Fainaro, R. (2020). Immune-mediated approaches against COVID-19. Nature Nanotechnology, 15, 630\u2013645.","journal-title":"Nature Nanotechnology"},{"key":"741_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V'Kovski","year":"2021","unstructured":"V\u2019Kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2021). Coronavirus biology and replication: Implications for SARS-CoV-2. Nature Reviews Microbiology, 19, 155\u2013170.","journal-title":"Nature Reviews Microbiology"},{"key":"741_CR4","doi-asserted-by":"publisher","first-page":"e28359","DOI":"10.1002\/jmv.28359","volume":"95","author":"D Luo","year":"2022","unstructured":"Luo, D., Li, T., Yang, X., Ning, N., Zhang, L., Gu, H., Li, D., Yu, W., Hu, Z., & Wang, H. (2022). The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection. Journal of Medical Virology, 95, e28359. https:\/\/doi.org\/10.1002\/jmv.28359","journal-title":"Journal of Medical Virology"},{"key":"741_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.980435","volume":"13","author":"Y Ji","year":"2022","unstructured":"Ji, Y., Zhang, Q., Cheng, L., Ge, J., Wang, R., Fang, M., Mucker, E. M., Chen, P., Ma, J., Zhang, R., Li, C., Hammond, H., Baracco, L., Holbrook, M., Frieman, M., Zhang, Z., Wang, X., Hooper, J. W., Zhang, L., & Zhu, Q. (2022). Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Frontiers in Immunology, 13, 980435.","journal-title":"Frontiers in Immunology"},{"key":"741_CR6","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1038\/s41467-022-33284-y","volume":"13","author":"Z Ku","year":"2022","unstructured":"Ku, Z., Xie, X., Lin, J., Gao, P., Wu, B., El Sahili, A., Su, H., Liu, Y., Ye, X., Tan, E. Y., Li, X., Fan, X., Goh, B. C., Xiong, W., Boyd, H., Muruato, A. E., Deng, H., Xia, H., Zou, J., \u2026 An, Z. (2022). Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth. Nature Communications, 13, 5552.","journal-title":"Nature Communications"},{"key":"741_CR7","doi-asserted-by":"publisher","first-page":"9943","DOI":"10.1126\/sciimmunol.abl9943","volume":"7","author":"PA Nikitin","year":"2022","unstructured":"Nikitin, P. A., DiMuzio, J. M., Dowling, J. P., Patel, N. B., Bingaman-Steele, J. L., Heimbach, B. C., Henriquez, N., Nicolescu, C., Polley, A., Sikorski, E. L., Howanski, R. J., Nath, M., Shukla, H., Scheaffer, S. M., Finn, J. P., Liang, L. F., Smith, T., Storm, N., McKay, L. G. A., \u2026 Robinson, M. K. (2022). IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA1 and BA2. Science Immunology, 7, 9943.","journal-title":"Science Immunology"},{"key":"741_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/antib11030057","volume":"11","author":"E Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez, E., Carballo-Uicab, G., Salinas-Trujano, J., Cort\u00e9s-Paniagua, M. I., V\u00e1zquez-Leyva, S., Vallejo-Castillo, L., Mendoza-Salazar, I., G\u00f3mez-Castellano, K., P\u00e9rez-Tapia, S. M., & Almagro, J. C. (2022). In vitro and in vivo characterization of a broadly neutralizing anti-SARS-CoV-2 antibody isolated from a semi-immune phage display library. Antibodies, 11, 57.","journal-title":"Antibodies (Basel)"},{"key":"741_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/antib11010013","volume":"11","author":"I Mendoza-Salazar","year":"2022","unstructured":"Mendoza-Salazar, I., G\u00f3mez-Castellano, K. M., Gonz\u00e1lez-Gonz\u00e1lez, E., Gamboa-Suasnavart, R., Rodr\u00edguez-Luna, S. D., Santiago-Casas, G., Cort\u00e9s-Paniagua, M. I., P\u00e9rez-Tapia, S. M., & Almagro, J. C. (2022). Anti-SARS-CoV-2 omicron antibodies isolated from a SARS-CoV-2 delta semi-immune phage display library. Antibodies, 11, 13.","journal-title":"Antibodies (Basel)"},{"key":"741_CR10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers, T. F., Zhao, F., Huang, D., Beutler, N., Burns, A., He, W. T., Limbo, O., Smith, C., Song, G., Woehl, J., Yang, L., Abbott, R. K., Callaghan, S., Garcia, E., Hurtado, J., Parren, M., Peng, L., Ramirez, S., Ricketts, J., \u2026 Burton, D. R. (2020). Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science, 369, 956\u2013963.","journal-title":"Science"},{"key":"741_CR11","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/pmic.200500579","volume":"6","author":"R Ohara","year":"2006","unstructured":"Ohara, R., Knappik, A., Shimada, K., Frisch, C., Ylera, F., & Koga, H. (2006). Antibodies for proteomic research: comparison of traditional immunization with recombinant antibody technology. Proteomics, 6, 2638\u20132646.","journal-title":"Proteomics"},{"key":"741_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2017.00022","volume":"8","author":"S Shigemori","year":"2017","unstructured":"Shigemori, S., & Shimosato, T. (2017). Applications of genetically modified immunobiotics with high immunoregulatory capacity for treatment of inflammatory bowel diseases. Frontiers in Immunology, 8, 22.","journal-title":"Frontiers in Immunology"},{"key":"741_CR13","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"18","author":"N Guex","year":"1997","unstructured":"Guex, N., & Peitsch, M. C. (1997). SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis, 18, 2714\u20132723.","journal-title":"Electrophoresis"},{"key":"741_CR14","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","volume":"31","author":"T Schwede","year":"2003","unstructured":"Schwede, T., Kopp, J., Guex, N., & Peitsch, M. C. (2003). SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Research, 31, 3381\u20133385.","journal-title":"Nucleic Acids Research"},{"key":"741_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00284-012-0111-x","volume":"64","author":"S Shigemori","year":"2012","unstructured":"Shigemori, S., Yonekura, S., Sato, T., Nakanishi, M., Otani, H., & Shimosato, T. (2012). Expression of a biologically active GFP-\u03b1(S1)-casein fusion protein in Lactococcus lactis. Current Microbiology, 64, 569\u2013575.","journal-title":"Current Microbiology"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.3168\/jds.2017-12872","volume":"100","author":"S Shigemori","year":"2017","unstructured":"Shigemori, S., Namai, F., Yamamoto, Y., Nigar, S., Sato, T., Ogita, T., & Shimosato, T. (2017). Genetically modified Lactococcus lactis producing a green fluorescent protein-bovine lactoferrin fusion protein suppresses proinflammatory cytokine expression in lipopolysaccharide-stimulated RAW 264.7 cells. Journal of Dairy Science, 100, 7007\u20137015.","journal-title":"Journal of Dairy Science"},{"key":"741_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00284-017-1354-3","volume":"75","author":"F Namai","year":"2018","unstructured":"Namai, F., Shigemori, S., Sudo, K., Sato, T., Yamamoto, Y., Nigar, S., Ogita, T., & Shimosato, T. (2018). Recombinant mouse osteocalcin secreted by Lactococcus lactis promotes glucagon-Like peptide-1 induction in STC-1 cells. Current Microbiology, 75, 92\u201398.","journal-title":"Current Microbiology"},{"key":"741_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00253-005-0107-6","volume":"68","author":"I Mierau","year":"2005","unstructured":"Mierau, I., & Kleerebezem, M. (2005). 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Applied Microbiology and Biotechnology, 68, 705\u2013717.","journal-title":"Applied Microbiology and Biotechnology"},{"key":"741_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s12033-020-00274-8","volume":"62","author":"F Namai","year":"2020","unstructured":"Namai, F., Murakami, A., Ueda, A., Tsukagoshi, M., Shigemori, S., Ogita, T., Sato, T., & Shimosato, T. (2020). Construction of genetically modified Lactococcus lactis producing anti-human-CTLA-4 single-chain fragment variable. Molecular Biotechnology, 62, 572\u2013579.","journal-title":"Molecular Biotechnology"},{"key":"741_CR20","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.1007\/s11033-020-05765-0","volume":"47","author":"F Namai","year":"2020","unstructured":"Namai, F., Shigemori, S., Ogita, T., Sato, T., & Shimosato, T. (2020). Construction of genetically modified Lactococcus lactis that produces bioactive anti-interleukin-4 single-chain fragment variable. Molecular Biology Report, 47, 7039-7047. https:\/\/doi.org\/10.1007\/s11033-020-05765-0","journal-title":"Molecular Biology Report"},{"key":"741_CR21","unstructured":"Organization, FAO and Organization WHO (2006) Probiotics in food: Health and nutritional properties and guidelines for evaluation, FAO"},{"key":"741_CR22","first-page":"e07408","volume":"20","author":"EP Hazards","year":"2022","unstructured":"Hazards, E. P., Koutsoumanis, K., Allende, A., Alvarez-Ordonez, A., Bolton, D., Bover-Cid, S., Chemaly, M., Davies, R., De Cesare, A., Hilbert, F., Lindqvist, R., Nauta, M., Peixe, L., Ru, G., Simmons, M., Skandamis, P., Suffredini, E., Cocconcelli, P. S., Fernandez Escamez, P. S., \u2026 Herman, L. (2022). Update of the list of QPS-recommended microbiological agents intentionally added to food or feed as notified to EFSA 16: suitability of taxonomic units notified to EFSA until March 2022. EFSA Journal, 20, e07408.","journal-title":"EFSA Journal"},{"key":"741_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrmicro1840","volume":"6","author":"JM Wells","year":"2008","unstructured":"Wells, J. M., & Mercenier, A. (2008). Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nature Review Microbiology, 6, 349\u2013362.","journal-title":"Nature Review Microbiology"},{"key":"741_CR24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/antiox9111049","volume":"9","author":"K Yumoto","year":"2020","unstructured":"Yumoto, K., Sato, T., Nakashima, K., Namai, F., Shigemori, S., Shimosato, T., & Kaneko, T. (2020). Nasally administered Lactococcus lactis secreting heme oxygenase-1 attenuates murine emphysema. Antioxidants (Basel), 9, 1049.","journal-title":"Antioxidants (Basel)"},{"key":"741_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00253-016-7907-8","volume":"101","author":"S Shigemori","year":"2017","unstructured":"Shigemori, S., Ihara, M., Sato, T., Yamamoto, Y., Nigar, S., Ogita, T., & Shimosato, T. (2017). Secretion of an immunoreactive single-chain variable fragment antibody against mouse interleukin 6 by Lactococcus lactis. Applied Microbiology and Biotechnology, 101, 341\u2013349.","journal-title":"Applied Microbiology and Biotechnology"},{"key":"741_CR26","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O'Toole","year":"2017","unstructured":"O\u2019Toole, P. W., Marchesi, J. R., & Hill, C. (2017). Next-generation probiotics: The spectrum from probiotics to live biotherapeutics. Nature Microbiology, 2, 17057.","journal-title":"Nature Microbiology"},{"key":"741_CR27","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s12276-020-00507-5","volume":"52","author":"F Namai","year":"2020","unstructured":"Namai, F., Shigemori, S., Ogita, T., Sato, T., & Shimosato, T. (2020). Microbial therapeutics for acute colitis based on genetically modified Lactococcus lactis hypersecreting IL-1Ra in mice. Experimental Molecular Medicine, 52, 1627\u20131636.","journal-title":"Experimental Molecular Medicine"},{"key":"741_CR28","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1084\/jem.20190609","volume":"216","author":"M Jimenez","year":"2019","unstructured":"Jimenez, M., Langer, R., & Traverso, G. (2019). Microbial therapeutics: new opportunities for drug delivery. Journal of Experimental Medicine, 216, 1005\u20131009.","journal-title":"Journal of Experimental Medicine"},{"key":"741_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00284-022-02866-w","volume":"79","author":"B Xuan","year":"2022","unstructured":"Xuan, B., Park, J., Yoo, J. H., & Kim, E. B. (2022). Oral immunization of mice with cell extracts from recombinant Lactococcus lactis expressing SARS-CoV-2 spike protein. Current Microbiology, 79, 167.","journal-title":"Current Microbiology"},{"key":"741_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/pharmaceutics14010076","volume":"14","author":"U Jancic","year":"2021","unstructured":"Jancic, U., & Gorgieva, S. (2021). Bromelain and nisin: the natural antimicrobials with high potential in biomedicine. Pharmaceutics, 14, 76.","journal-title":"Pharmaceutics"},{"key":"741_CR31","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3390\/vaccines10111880","volume":"10","author":"JM Sabu","year":"2022","unstructured":"Sabu, J. M., Zahid, I., Jacob, N., Alele, F. O., & Malau-Aduli, B. S. (2022). Effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine in children and adolescents: a systematic review and meta-analysis. Vaccines, 10, 1880.","journal-title":"Vaccines"},{"key":"741_CR32","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/asj.13115","volume":"89","author":"F Namai","year":"2018","unstructured":"Namai, F., Yamamoto, Y., Sato, T., Ogita, T., & Shimosato, T. (2018). Recombinant mouse calcitonin gene-related peptide secreted by Lactococcus lactis inhibits lipopolysaccharide-induced inflammatory response in macrophages. Animal Science Journal, 89, 1707\u20131711.","journal-title":"Animal Science Journal"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00741-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00741-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T05:08:40Z","timestamp":1705468120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00741-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00741-y","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest or competing interests related to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}